Volume 44 (2026) – Supplementary Issue 1 – Article 16 – Epitheorese Klinikes Farmakologias kai Farmakokinetikes

Open Access Research

Effects of chrysanthemin on oxidative stress, TNF-α, and FGL1 in imiquimod-induced psoriasis-like dermatitis in rats
Noor AL-Shanan1,*A green circle with white letters Description automatically generated, Ghaith ALZubaidy1,2A green circle with white letters Description automatically generated, Raghad AL-Shammary1A green circle with white letters Description automatically generated
1College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
2College of Health and Medical Techniques, Al-Bayan University, Baghdad, Iraq

*Corresponding author: Noor AL-Shanan, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq; Tel: +9647883683973; e-mail: nooralfra6@uomustansiriyah.edu.iq


Download PDF

Published: 2026 ; https://doi.org/10.61873/


Abstract
Background: Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperproliferation, exces­sive cytokine production, and oxidative stress. Over time, these processes disrupt cellular redox homeostasis and dysregulate the immune system. Consequently, there is an increasing interest in investigating natural bioactive com­pounds. Chrysanthemin (cyanidin-3-O-glucoside), a plant-derived anthocyanin abundant in pigmented fruits, has re­ceived special attention for its documented antioxidant and anti-inflammatory activities. Aim: This study investigated the effects of chrysanthemin on oxidative stress, tumor necrosis factor-alpha (TNF-α), and the systemic immune checkpoint protein fibrinogen-like protein 1 (FGL1) in an imiquimod (IMQ)-induced psoriasis-like rat model. Methodology: Thirty-six male Wistar rats were randomly allocated into six groups (n=6). Psoriasis-like dermatitis was induced by topical 5% IMQ cream for 7 days. Following IMQ discontinuation, animals received a 10-day treatment with either vehicle (induction control), standard topical clobetasol (0.05%), oral chrysanthemin (40 mg/kg/day), topical 2% chry­santhemin gel, combination of oral chrysanthemin and topical clobetasol. Serum FGL1, superoxide dismutase (SOD), and glutathione (GSH), as well as tissue malondialdehyde (MDA), were measured via ELISA. Epidermal TNF-α ex­pression was evaluated by immunohistochemistry. Results: IMQ exposure significantly decreased antioxidant de­fenses and elevated inflammatory markers. The combination therapy (oral chrysanthemin + topical clobetasol) demonstrated the most prominent protective response compared to the untreated induction group, significantly re­storing serum SOD (912.93 ± 16.47 vs. 464.60 ± 27.87 pg/mL) and GSH (86.85 ± 3.75 vs. 35.31 ± 2.32 µg/mL), and reducing tissue MDA (199.35 ± 1.89 vs. 457.44 ± 1.66 ng/mL) and serum FGL1 (0.98 ± 0.06 vs. 3.97 ± 0.64 ng/mL) (p<0.05 for all). Furthermore, the median immunoreactive score (IRS) for TNF-α was markedly reduced to 1 in the combination group, compared to 10.5 in the induction group. Conclusion: Chrysanthemin improved oxidative stress and inflammatory biomarker profiles, including TNF-α and FGL1, in this psoriasis-like rat model. While these findings suggest its potential role in restoring redox homeostasis and modulating inflammatory pathways, further studies are required to fully establish its mechanistic therapeutic efficacy.

Keywor
ds:
psoriasis, chrysanthemin, oxidative stress, TNF-α, FGL1

Please cite as: Al-Shanan N., ALZubaidy G., Al-Shammary R.: Effects of chrysanthemin on oxidative stress, TNF-α, and FGL1 in imiquimod-induced psoriasis-like dermatitis in rats. Epitheorese Klin. Farmakol. Farmakokinet. xx(xx): xx-xx (2026). DOI: 10.61873/XXXXXXX

 


pISSN 1011-6575 • eISSN 2945-1914

Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.